All News

Making Collaborative Care Work: Overcoming Barriers to Integrating Mental Health in Primary Care
April 21, 2025

ACP 2025: Collaborative care can help address the mental health crisis, but payment and EHR challenges remain. Matthew Press, MD, explains how primary care can overcome these barriers and why integration is essential.

Untreated Depression, Anxiety Worsen COPD Outcomes: Daily Dose
April 21, 2025

Your daily dose of the clinical news you may have missed.

Smart Ring Outperforms Apple Watch for Atrial Fibrillation Detection
April 21, 2025

The CART ring was superior to the Apple Watch in automated AF detection with fewer unclassified ECGs, but neither device should serve as a definitive diagnostic tool.

The Road to RSV Vaccines in the US: A Timeline Topline
April 21, 2025

Respiratory syncytial virus was deadly and untreatable across the lifespan until 2023 when the first vaccines were approved in the US. Follow the timeline, here.

HbA1c is Good for the Big Diabetes Picture but CGM is Key for the Data Close-Up
April 18, 2025

ACP 2025. The timely glucose data available with continuous glucose monitoring is what's needed for optimal daily diabetes control, says Tom Martens, MD.

Pancreatic, Colorectal Cancer Rates Rising in Young Adults Nationwide, Study Warns
April 18, 2025

The increase in pancreatic cancer among Americans aged 15 to 34 is particularly alarming and should alert clinicians to heed relevant GI symptoms as suspicious.

FDA Approves Dupilumab for Chronic Spontaneous Urticaria Uncontrolled by Antihistamines
April 18, 2025

Dupilumab (Dupixent) is the first new targeted therapy for CSU in over a decade.

Patient Navigation Program Improves Colonoscopy Completion Rates After Abnormal FIT Results
April 18, 2025

The phone-based patient navigation intervention addressed barriers to CRC testing follow-up and included patient education.

Emerging Therapies Show Potential for Hard-to-Treat Chronic Spontaneous Urticaria
April 18, 2025

New data highlight the potential of dupilumab, remibrutinib, and barzolvolimab to expand treatment options for patients with CSU unresponsive to current therapies.

Elinzanetant Reduces Vasomotor Symptoms of Menopause Across BMI, Smoking Status
April 18, 2025

Pooled data from the OASIS clinical trial program showed consistent efficacy of elinzanetant across BMI and smoking history subgroups, highlighting its broad applicability.